Glycosade v UCCS in the Dietary Management of Hepatic GSD

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions
Glycogen Storage Disease
Interventions
DIETARY_SUPPLEMENT

Medical Food - Glycosade

double blind randomised crossover of 2 starches - glycosade and UCCS

Trial Locations (6)

06106

Connecticut Children's Medical Center, Hartford

92140 Cedex

Hôpital Antoine Béclère, Clamart

9700RB

Universitair Medisch Centrum Groningen, Groningen

WC1N 3BG

National Hospital for Neurology and Neurosurgery, London

Unknown

Evelina Children's Hospital, London

Great Ormond Street Hospital for Children, London

All Listed Sponsors
collaborator

University College London Hospitals

OTHER

collaborator

University of Florida

OTHER

collaborator

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Hôpital Necker-Enfants Malades

OTHER

lead

Vitaflo International, Ltd

INDUSTRY

NCT02318966 - Glycosade v UCCS in the Dietary Management of Hepatic GSD | Biotech Hunter | Biotech Hunter